Magnin Josephine, Jolissaint Joshua S, Fuchs Hannah E, Seier Kenneth, Gonen Mithat, Barekzai Ahmad, Balachandran Vinod P, D'Angelica Michael I, Drebin Jeffrey A, Kingham T Peter, Soares Kevin, Wei Alice C, Jarnagin William R
Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Digestive Surgical Oncology, University Hospital of Dijon, Dijon, France.
Ann Surg. 2024 Jun 28. doi: 10.1097/SLA.0000000000006425.
To assess whether selective omission of operative drains after pancreaticoduodenectomy (PD) and distal pancreatectomy (DP) is associated with adverse perioperative outcomes.
The routine use of operative drains after pancreatectomy is widely practiced; however, prospective randomized clinical trials and retrospective analyses have shown mixed results.
Patients who underwent PD or DP between November 2009 and May 2021 were reviewed and stratified by operative drain placement. Patient demographics, morbidity, the need for additional procedures, and mortality were compared between patients who did or did not develop a clinically relevant post-operative pancreatic fistula (CR-POPF).
In total, 1,855 PD and 752 DP cases were analyzed. Among PD patients with a CR-POPF (N=259, 14%), 160 (62%) had an operative drain placed, of whom 141 (88%) required at least 1 additional procedure. Within this subgroup, grade ≥ 4 complications (7.5% vs. 11.1%, P=0.37), 90-day mortality (3.8% vs. 6.1%, P=0.54), length of stay (LOS) (median 12 vs. 13 d, P=0.19) and readmission rates (63.1% vs. 54.6%, P=0.19) were similar between drained and non-drained patients. Of note, drained PD patients without a CR-POPF had a longer hospital stay (8 vs. 7 d, respectively, P=0.004) and more thromboembolic events (2.4% vs. 1.1%, respectively, P=0.04) Among DP patients with a CR-POPF (n=129), 44 had an operative drain, with 37 (84%) requiring an additional procedure. Within this subgroup, grade ≥ 4 complications (4.6% vs. 5.9%, P>0.95), 90-day mortality (0%), LOS (median 7 d for both, P=0.88) and readmission rates (72.7% vs. 80%, P=0.38) were similar in drained and non-drained patients.
This study confirms that selective omission of operative drains does not compromise perioperative outcomes, as initially reported in our prospective randomized trial.
评估胰十二指肠切除术(PD)和胰体尾切除术(DP)后选择性不放置手术引流管是否与围手术期不良结局相关。
胰腺切除术后常规放置手术引流管的做法广泛存在;然而,前瞻性随机临床试验和回顾性分析的结果不一。
对2009年11月至2021年5月期间接受PD或DP手术的患者进行回顾,并根据手术引流管的放置情况进行分层。比较发生或未发生临床相关术后胰瘘(CR-POPF)的患者的人口统计学特征、发病率、是否需要额外手术以及死亡率。
共分析了1855例PD和752例DP病例。在发生CR-POPF的PD患者中(N = 259,14%),160例(62%)放置了手术引流管,其中141例(88%)需要至少进行1次额外手术。在这个亚组中,4级及以上并发症(7.5%对11.1%,P = 0.37)、90天死亡率(3.8%对6.1%,P = 0.54)、住院时间(LOS)(中位数12天对13天,P = 0.19)和再入院率(63.1%对54.6%,P = 0.19)在放置引流管和未放置引流管的患者之间相似。值得注意的是,未发生CR-POPF的放置引流管的PD患者住院时间更长(分别为8天和7天,P = 0.004),血栓栓塞事件更多(分别为2.4%和1.1%,P = 0.04)。在发生CR-POPF的DP患者中(n = 129),44例放置了手术引流管,其中37例(84%)需要额外手术。在这个亚组中,4级及以上并发症(4.6%对5.9%,P>0.95)、90天死亡率(0%)、LOS(两者中位数均为7天,P = 0.88)和再入院率(72.7%对80%,P = 0.38)在放置引流管和未放置引流管的患者之间相似。
本研究证实,如我们之前前瞻性随机试验最初报道的那样,选择性不放置手术引流管不会影响围手术期结局。